Breaking News Instant updates and real-time market news.

NOVN

Novan

$1.47

0.075 (5.38%)

11:25
12/10/18
12/10
11:25
12/10/18
11:25

Novan 'highly undervalued' after 'best-case' data, says H.C. Wainwright

H.C. Wainwright analyst Oren Livnat says Novan's new new Phase 2 data "should settle some earlier pushback." The "definitively positive and statistically significant" results of the 12% once-daily dose represent a "best-case scenario," Livnat tells investors in a research note. These data bolster the analyst's confidence that SB206 is an "effective, well-tolerated molluscum treatment, and that a higher-powered Phase 3 will work." He continues to see Novan as "highly undervalued," and a "likely eventual takeout candidate if and when its pipeline comes to fruition." Livnat lowered his price target for the shares to $6 from $8 to reflect higher projected dilution than previously modeled and reiterates a Buy rating on the name.

NOVN Novan
$1.47

0.075 (5.38%)

10/26/18
10/26/18
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. L Brands (LB) initiated with a Buy at Goldman Sachs while Gap (GPS) was initiated with a Neutral. 2. Iridex (IRIX) initiated with a Buy at Stifel. 3. Xilinx (XLNX) assumed with a Market Perform at William Blair. 4. Novan (NOVN) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/18
HCWC
10/26/18
INITIATION
Target $8
HCWC
Buy
Novan initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat started Novan with a Buy rating and $8 price target. The company is built around a proprietary platform technology that allows stable, solid chemical storage and controlled delivery of therapeutic quantities of nitric oxide, Livnat tells investors in a research note. He believes Novan is the only company to "reliably harness meaningful NO concentrations to formulate topical NO therapies."
05/21/18
JMPS
05/21/18
NO CHANGE
JMPS
Novan Q1 results beat estimates, pipeline progressing, says JMP Securities
JMP Securities analyst Donald Ellis noted that Novan reported Q1 earnings that were ahead of JMP's estimate and the consensus estimate, and added that the company's pipeline is progressing with multiple Phase 1/Phase 2 study top-line results expected later this year. Ellis reiterated a Market Outperform rating and $14 price target on Novan shares.

TODAY'S FREE FLY STORIES

VCEL

Vericel

$18.80

-0.41 (-2.13%)

06:52
11/14/19
11/14
06:52
11/14/19
06:52
Conference/Events
Vericel management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ECOR

electroCore

$1.88

0.06 (3.30%)

06:51
11/14/19
11/14
06:51
11/14/19
06:51
Recommendations
electroCore analyst commentary  »

electroCore price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$66.03

-0.76 (-1.14%)

06:50
11/14/19
11/14
06:50
11/14/19
06:50
Conference/Events
UMB Financial management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

NVDA

Nvidia

$208.55

-1 (-0.48%)

06:50
11/14/19
11/14
06:50
11/14/19
06:50
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

UBX

Unity Biotechnology

$6.56

-0.21 (-3.10%)

06:49
11/14/19
11/14
06:49
11/14/19
06:49
Conference/Events
Unity Biotechnology management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 13

    Dec

TRGP

Targa Resources

$38.31

-0.5 (-1.29%)

06:47
11/14/19
11/14
06:47
11/14/19
06:47
Conference/Events
Targa Resources management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

SACH

Sachem Capital

$4.26

-0.04 (-0.93%)

06:46
11/14/19
11/14
06:46
11/14/19
06:46
Initiation
Sachem Capital initiated  »

Sachem Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCOM

Trip.com Group

$32.74

-1.03 (-3.05%)

06:46
11/14/19
11/14
06:46
11/14/19
06:46
Recommendations
Trip.com Group analyst commentary  »

Trip.com Group should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STIM

Neuronetics

$4.44

-0.39 (-8.07%)

06:44
11/14/19
11/14
06:44
11/14/19
06:44
Conference/Events
Neuronetics management to meet with BTIG »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

NTAP

NetApp

$60.04

-0.08 (-0.13%)

06:44
11/14/19
11/14
06:44
11/14/19
06:44
Recommendations
NetApp analyst commentary  »

NetApp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 12

    Dec

SBH

Sally Beauty

$19.50

-0.45 (-2.26%)

06:43
11/14/19
11/14
06:43
11/14/19
06:43
Downgrade
Sally Beauty rating change  »

Sally Beauty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

SRNE

Sorrento Therapeutics

$1.58

-0.025 (-1.56%)

06:43
11/14/19
11/14
06:43
11/14/19
06:43
Conference/Events
Sorrento Therapeutics management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PING

Ping Identity

$16.50

-0.25 (-1.49%)

06:42
11/14/19
11/14
06:42
11/14/19
06:42
Recommendations
Ping Identity analyst commentary  »

Ping Identity price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CACC

Credit Acceptance

$430.08

-3.57 (-0.82%)

06:40
11/14/19
11/14
06:40
11/14/19
06:40
Recommendations
Credit Acceptance analyst commentary  »

Credit Acceptance price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$18.52

-0.69 (-3.59%)

06:39
11/14/19
11/14
06:39
11/14/19
06:39
Earnings
Canopy Growth reports Q2 EPS (C$1.08) vs. (C$1.52) last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

T

AT&T

$39.15

-0.03 (-0.08%)

, VZ

Verizon

$59.41

0.07 (0.12%)

06:39
11/14/19
11/14
06:39
11/14/19
06:39
Downgrade
AT&T, Verizon, T-Mobile, Altice USA, Comcast, Dish, Sprint rating change  »

HSBC downgrades AT&T,…

T

AT&T

$39.15

-0.03 (-0.08%)

VZ

Verizon

$59.41

0.07 (0.12%)

TMUS

T-Mobile

$78.02

0.57 (0.74%)

ATUS

Altice USA

$26.84

0.33 (1.24%)

CMCSA

Comcast

$45.21

-0.02 (-0.04%)

DISH

Dish

$35.66

-0.37 (-1.03%)

S

Sprint

$6.07

0.215 (3.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 29

    Jan

  • 30

    Jan

CSCO

Cisco

$48.44

0.06 (0.12%)

06:37
11/14/19
11/14
06:37
11/14/19
06:37
Recommendations
Cisco analyst commentary  »

Cisco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 12

    Feb

LNT

Alliant Energy

$52.60

0.9 (1.74%)

06:34
11/14/19
11/14
06:34
11/14/19
06:34
Syndicate
Alliant Energy files to sell $195.6M in common stock »

Barclays Capital Inc. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PXS

Pyxis Tankers

$1.01

-0.08 (-7.34%)

06:34
11/14/19
11/14
06:34
11/14/19
06:34
Earnings
Pyxis Tankers reports Q3 EPS (4c), consensus (4c) »

Reports Q3 revenue $7.3M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

FB

Facebook

$193.20

-1.27 (-0.65%)

06:33
11/14/19
11/14
06:33
11/14/19
06:33
Periodicals
Facebook looked to buy Musical.ly in 2016, BuzzFeed News reports »

Facebook spent the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REPL

Replimune Group

$13.55

-3.3 (-19.58%)

06:33
11/14/19
11/14
06:33
11/14/19
06:33
Syndicate
Replimune Group 3.678M share Secondary priced at $13.61 »

The deal size was reduced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CERC

Cerecor

$3.28

-0.07 (-2.09%)

06:32
11/14/19
11/14
06:32
11/14/19
06:32
Earnings
Cerecor reports Q3 EPS (7c), consensus (13c) »

Reports Q3 revenue $5.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$42.94

-0.05 (-0.12%)

06:30
11/14/19
11/14
06:30
11/14/19
06:30
Earnings
GDS Holdings reports Q3 EPS (12c), consensus (8c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 09

    Dec

AAPL

Apple

$264.52

2.63 (1.00%)

06:30
11/14/19
11/14
06:30
11/14/19
06:30
Periodicals
Apple Watch detects irregular heartbeats in study, Reuters reports »

Apple's Heart study,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$65.25

-0.03 (-0.05%)

06:30
11/14/19
11/14
06:30
11/14/19
06:30
Downgrade
Albemarle rating change  »

Albemarle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.